PubMed

Prime-boost vaccination with plasmid and adenovirus gene vaccines control HER2/neu+ metastatic breast cancer in mice.

Wang X, Wang JP, Rao XM, Price JE, Zhou HS, Lachman LB.

Breast Cancer Res. 2005;7(5):R580-8. Epub 2005 May 23.PMID: 16168101 [PubMed - indexed for MEDLINE]Related articlesFree article

DNA vaccination against neu reduces breast cancer incidence and metastasis in mice.

Lachman LB, Rao XM, Kremer RH, Ozpolat B, Kiriakova G, Price JE.

Cancer Gene Ther. 2001 Apr;8(4):259-68.PMID: 11393278 [PubMed - indexed for MEDLINE]Related articlesFree article

Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model.

Eralp Y, Wang X, Wang JP, Maughan MF, Polo JM, Lachman LB.

Breast Cancer Res. 2004;6(4):R275-83. Epub 2004 Apr 7.PMID: 15217493 [PubMed - indexed for MEDLINE]Related articlesFree article

Adenovirus vaccination against neu oncogene exerts long-term protection from tumorigenesis in BALB/neuT transgenic mice.

Gallo P, Dharmapuri S, Nuzzo M, Maldini D, Cipriani B, Forni G, Monaci P.

Int J Cancer. 2007 Feb 1;120(3):574-84.PMID: 17096348 [PubMed - indexed for MEDLINE]Related articles

Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.

Wei H, Wang S, Zhang D, Hou S, Qian W, Li B, Guo H, Kou G, He J, Wang H, Guo Y.

Clin Cancer Res. 2009 Jul 15;15(14):4612-21. Epub 2009 Jul 7.PMID: 19584156 [PubMed - indexed for MEDLINE]Related articles

Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice.

Sakai Y, Morrison BJ, Burke JD, Park JM, Terabe M, Janik JE, Forni G, Berzofsky JA, Morris JC.

Cancer Res. 2004 Nov 1;64(21):8022-8.PMID: 15520211 [PubMed - indexed for MEDLINE]Related articlesFree article

Alphavirus replicon particles containing the gene for HER2/neu inhibit breast cancer growth and tumorigenesis.

Wang X, Wang JP, Maughan MF, Lachman LB.

Breast Cancer Res. 2005;7(1):R145-55. Epub 2004 Nov 29.PMID: 15642163 [PubMed - indexed for MEDLINE]Related articlesFree article

Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector.

Gallo P, Dharmapuri S, Nuzzo M, Maldini D, Iezzi M, Cavallo F, Musiani P, Forni G, Monaci P.

Int J Cancer. 2005 Jan 1;113(1):67-77.PMID: 15386429 [PubMed - indexed for MEDLINE]Related articles

Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice.

Nanni P, Nicoletti G, De Giovanni C, Landuzzi L, Di Carlo E, Cavallo F, Pupa SM, Rossi I, Colombo MP, Ricci C, Astolfi A, Musiani P, Forni G, Lollini PL.

J Exp Med. 2001 Nov 5;194(9):1195-205.PMID: 11696586 [PubMed - indexed for MEDLINE]Related articlesFree article

Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination.

Pupa SM, Iezzi M, Di Carlo E, Invernizzi A, Cavallo F, Meazza R, Comes A, Ferrini S, Musiani P, Ménard S.

Cancer Res. 2005 Feb 1;65(3):1071-8.PMID: 15705909 [PubMed - indexed for MEDLINE]Related articlesFree article

Vaccination with the extracellular domain of p185neu prevents mammary tumor development in neu transgenic mice.

Esserman LJ, Lopez T, Montes R, Bald LN, Fendly BM, Campbell MJ.

Cancer Immunol Immunother. 1999 Feb;47(6):337-42.PMID: 10203064 [PubMed - indexed for MEDLINE]Related articles

Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice.

Wagner S, Jasinska J, Breiteneder H, Kundi M, Pehamberger H, Scheiner O, Zielinski CC, Wiedermann U.

Breast Cancer Res Treat. 2007 Nov;106(1):29-38. Epub 2007 Jan 3.PMID: 17203384 [PubMed - indexed for MEDLINE]Related articles

p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.

Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P.

Cancer Res. 2006 May 1;66(9):4672-80.PMID: 16651418 [PubMed - indexed for MEDLINE]Related articlesFree article

The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer.

Chang JY, Xia W, Shao R, Sorgi F, Hortobagyi GN, Huang L, Hung MC.

Oncogene. 1997 Feb 6;14(5):561-8.PMID: 9053854 [PubMed - indexed for MEDLINE]Related articlesFree article

The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors.

Reilly RT, Machiels JP, Emens LA, Ercolini AM, Okoye FI, Lei RY, Weintraub D, Jaffee EM.

Cancer Res. 2001 Feb 1;61(3):880-3.PMID: 11221874 [PubMed - indexed for MEDLINE]Related articlesFree article

Expansion of HER2/neu-specific T cells ex vivo following immunization with a HER2/neu peptide-based vaccine.

Knutson KL, Disis ML.

Clin Breast Cancer. 2001 Apr;2(1):73-9. Review.PMID: 11899386 [PubMed - indexed for MEDLINE]Related articlesFree article

The mannosylated extracellular domain of Her2/neu produced in P. pastoris induces protective antitumor immunity.

Dimitriadis A, Gontinou C, Baxevanis CN, Mamalaki A.

BMC Cancer. 2009 Oct 30;9:386.PMID: 19878568 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy of vaccination with plasmid DNA encoding for HER2/neu or HER2/neu-eGFP fusion protein against prostate cancer in rats.

Bhattachary R, Bukkapatnam R, Prawoko I, Soto J, Morgan M, Salup RR.

Int Immunopharmacol. 2002 May;2(6):783-96.PMID: 12095169 [PubMed - indexed for MEDLINE]Related articles

HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice.

Reilly RT, Gottlieb MB, Ercolini AM, Machiels JP, Kane CE, Okoye FI, Muller WJ, Dixon KH, Jaffee EM.

Cancer Res. 2000 Jul 1;60(13):3569-76.PMID: 10910070 [PubMed - indexed for MEDLINE]Related articlesFree article

LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice.

Cappello P, Triebel F, Iezzi M, Caorsi C, Quaglino E, Lollini PL, Amici A, Di Carlo E, Musiani P, Giovarelli M, Forni G.

Cancer Res. 2003 May 15;63(10):2518-25.PMID: 12750275 [PubMed - indexed for MEDLINE]Related articlesFree article